In last trading session, Sensus Healthcare Inc (NASDAQ:SRTS) saw 0.71 million shares changing hands with its beta currently measuring 1.22. Company’s recent per share price level of $8.23 trading at $1.36 or 19.87% at ring of the bell on the day assigns it a market valuation of $134.97M. That closing price of SRTS’s stock is at a discount of -13.37% from its 52-week high price of $9.33 and is indicating a premium of 64.64% from its 52-week low price of $2.91. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.2 million shares which gives us an average trading volume of 234.95K if we extend that period to 3-months.
For Sensus Healthcare Inc (SRTS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.12 in the current quarter.
Sensus Healthcare Inc (NASDAQ:SRTS) trade information
Upright in the green during last session for gaining 19.87%, in the last five days SRTS remained trading in the green while hitting it’s week-highest on Friday, 01/31/25 when the stock touched $8.23 price level, adding 2.37% to its value on the day. Sensus Healthcare Inc’s shares saw a change of 19.00% in year-to-date performance and have moved 15.34% in past 5-day. Sensus Healthcare Inc (NASDAQ:SRTS) showed a performance of 14.85% in past 30-days. Number of shares sold short was 0.54 million shares which calculate 6.14 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 17.7% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -21.51% in reaching the projected high whereas dropping to the targeted low would mean a loss of -21.51% for stock’s current value.
Sensus Healthcare Inc (SRTS) estimates and forecasts
Statistics highlight that Sensus Healthcare Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 29.28% of value to its shares in past 6 months, showing an annual growth rate of 1,266.67% while that of industry is 14.40. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 62.22% from the last financial year’s standing.
4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 10.53M for the same. And 4 analysts are in estimates of company making revenue of 10.39M in the next quarter. Company posted 12.57M and 10.66M of sales in current and next quarters respectively a year earlier.
Sensus Healthcare Inc (NASDAQ:SRTS)’s Major holders
Insiders are in possession of 19.01% of company’s total shares while institution are holding 24.27 percent of that, with stock having share float percentage of 29.97%. Investors also watch the number of corporate investors in a company very closely, which is 24.27% institutions for Sensus Healthcare Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at SRTS for having 0.78 million shares of worth $4.15 million. And as of 2024-06-30, it was holding 4.7809 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.39 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.4028 of outstanding shares, having a total worth of $2.09 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 555.56 shares of worth $4.58 million or 3.39% of the total outstanding shares. The later fund manager was in possession of 207.42 shares on Sep 30, 2024 , making its stake of worth around $1.71 million in the company or a holder of 1.27% of company’s stock.
